Literature DB >> 671818

[Lipid peroxides in atherosclerotic diseases (author's transl)].

C Naito, T Yamanaka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 671818

Source DB:  PubMed          Journal:  Nihon Ronen Igakkai Zasshi        ISSN： 0300-9173


× No keyword cloud information.
  5 in total

1.  Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney.

Authors:  Hyun Ju Kim; Hamid Moradi; Jun Yuan; Keith Norris; Nosratola D Vaziri
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-08

2.  Dietary cyanidin 3-O-beta-D-glucoside increases ex vivo oxidation resistance of serum in rats.

Authors:  T Tsuda; F Horio; T Osawa
Journal:  Lipids       Date:  1998-06       Impact factor: 1.880

3.  Effect of H2 treatment in a mouse model of rheumatoid arthritis-associated interstitial lung disease.

Authors:  Yasuhiro Terasaki; Mika Terasaki; Satoshi Kanazawa; Nariaki Kokuho; Hirokazu Urushiyama; Yusuke Kajimoto; Shinobu Kunugi; Motoyo Maruyama; Toshio Akimoto; Yoko Miura; Tsutomu Igarashi; Ikuroh Ohsawa; Akira Shimizu
Journal:  J Cell Mol Med       Date:  2019-08-19       Impact factor: 5.310

4.  The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease.

Authors:  Mohammad A Aminzadeh; Scott A Reisman; Nosratola D Vaziri; Mahyar Khazaeli; Jun Yuan; Colin J Meyer
Journal:  Xenobiotica       Date:  2013-11-06       Impact factor: 1.908

5.  Evaluation of antidiabetic, antioxidant and antiglycating activities of the Eysenhardtia polystachya.

Authors:  Rosa Martha Perez Gutierrez; Efren Garcia Baez
Journal:  Pharmacogn Mag       Date:  2014-04       Impact factor: 1.085
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.